Akebia Therapeutics, Inc.

Historical 13F Holders

Symbol
AKBA
CUSIP
00972D105
All holders as of
Q4 2023
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2024 Q1 21 1.24 M $2.25 M
2023 Q4 95 54.8 M $68.0 M
2023 Q3 82 50.9 M $58.0 M
2023 Q2 85 50.3 M $46.0 M
2023 Q1 70 52.0 M $30.9 M
2022 Q4 82 52.8 M $31.2 M
2022 Q3 96 52.2 M $16.5 M
2022 Q2 104 57.5 M $20.3 M
2022 Q1 150 81.3 M $58.4 M
2021 Q4 147 98.0 M $221 M
2021 Q3 132 97.9 M $282 M
2021 Q2 148 106 M $400 M
2021 Q1 155 99.9 M $338 M
2020 Q4 159 105 M $299 M
2020 Q3 178 101 M $267 M
2020 Q2 201 111 M $1.51 B
2020 Q1 167 92.3 M $700 M
2019 Q4 164 85.6 M $541 M
2019 Q3 162 84.7 M $332 M
2019 Q2 169 86.7 M $419 M
2019 Q1 181 84.3 M $690 M
2018 Q4 177 81.6 M $451 M
2018 Q3 142 42.8 M $378 M
2018 Q2 152 43.0 M $537 M
2018 Q1 158 43.9 M $416 M
2017 Q4 135 33.7 M $501 M
2017 Q3 123 30.1 M $593 M
2017 Q2 123 27.3 M $392 M
2017 Q1 96 21.7 M $199 M
2016 Q4 102 21.0 M $219 M
2016 Q3 95 19.6 M $177 M
2016 Q2 106 19.6 M $147 M
2016 Q1 99 21.1 M $191 M
2015 Q4 97 16.3 M $209 M
2015 Q3 86 18.7 M $184 M
2015 Q2 76 13.1 M $146 M
2015 Q1 64 7.47 M $88.3 M
2014 Q4 58 7.56 M $94.5 M
2014 Q3 55 8.01 M $180 M
2014 Q2 53 8.74 M $243 M
2014 Q1 3 104 k $2.03 M